Mass Tort brief
London Courts Tighten Mass Litigation Precedents
Appellate cost rulings against BHP, Mercedes trial orders, and a £1bn blood redress expansion raise the stakes for British liability defense.
Mass Tort
The High Court refused to pause the dieselgate battle — sending Mercedes to a high-stakes quantum trial that will set UK vehicle payout formulas.
BackgroundThe Pan-NOx group litigation represents 1.6 million British vehicle owners across 13 Group Litigation Orders seeking damages for unlawful emissions-defeat software. Lady Justice Cockerill's earlier liability judgment found defeat devices in only a limited subset of Mercedes vehicles while clearing other major carmakers.
- Mr Justice Constable ruled that calculating breach-of-contract damages against Mercedes has critical utility for resolving claims across the broader litigation, rejecting claimants' proposed stay.
- Claimant law firms Leigh Day and Pogust Goodhead have concurrently applied to the Court of Appeal to challenge restrictive judicial rulings on defeat devices, seeking wider liability grounds.
- Automotive liability analysts noted a substantial damages verdict against Mercedes could establish expensive compensation precedents for European motor manufacturers facing parallel emissions class actions.
Mass Tort
The Court of Appeal penalised BHP for procedural delays — forcing corporate defendants to cover escalating interest costs on claimant funding agreements.
BackgroundThe 2015 Fundão tailings dam collapse in Mariana, Brazil, killed 19 people and released 40 million cubic metres of toxic mining waste into the Doce River. Over 450,000 Brazilian victims, indigenous communities, and local municipalities filed claims in London courts to hold BHP liable for catastrophic damages.
- Master of the Rolls Sir Geoffrey Vos ruled the High Court has clear jurisdiction to award pre-judgment interest on legal costs in CFA-funded mass litigation, deterring delay tactics.
- BHP must pay 90% of claimants' Stage 1 costs plus interest at 1% above the Bank of England base rate, alongside an immediate £43m interim payment on account.
- The appellate precedent strengthens litigation funders' balance sheets ahead of scheduled Stage 2 liability and quantum trials, lowering financing risks across large cross-border environmental claims.
Mass Tort
Swiss Re warned that expanding collective actions could saddle UK businesses with £11.9bn in damages — prompting insurers to demand statutory caps on litigation funders.
BackgroundSocial inflation describes the phenomenon where aggressive plaintiff litigation, third-party financing, and shifting societal views expand liability settlements faster than general economic growth. Proposed legislative reforms seek to reverse the Supreme Court's PACCAR ruling to protect third-party litigation funding agreements.
- The report noted non-economic claims inflation added 5 to 6 percentage points annually to corporate liability claim costs across British commercial sectors, outpacing headline inflation.
- Commercial insurers called on Westminster to mandate full disclosure of litigation funding contracts and restrict third-party control over case settlements, warning against runaway litigation.
- Risk analysts warned that without statutory safeguards, rising litigation costs will inevitably drive up professional indemnity insurance premiums for UK employers across high-risk industrial sectors.
Mass Tort
Ministers expanded infected blood redress to £12.8bn — widening compensation to family carers after decades of state denial.
BackgroundDuring the 1970s and 1980s, more than 30,000 NHS patients contracted HIV and hepatitis C through contaminated blood transfusions and imported blood-clotting factor products. Inquiry chair Sir Brian Langstaff recommended establishing an independent compensation authority to distribute full financial restitution to victims.
- The expanded scheme eases administrative barriers for partners, parents, and informal carers of infected patients who were previously excluded from initial awards, expediting payments.
- Supplementary compensation packages were approved for surviving haemophilia patients infected during clinical trials conducted at Lord Mayor Treloar College, addressing institutional negligence.
- Specialist litigation firms are expanding clinical negligence and human rights teams to assist thousands of newly eligible applicants submitting claims to the independent authority.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
